BTI-322 rat monoclonal antibody targeting the CD2 molecule on T and NK cells: Phase II testing

MedImmune Inc. (MEDI), Gaithersburg, Md.
Product:

Read the full 66 word article

How to gain access

Continue reading with a
two-week free trial.